From the Research
Requip is the brand name of ropinirole. This medication is primarily used to treat Parkinson's disease and restless legs syndrome (RLS) 1. Ropinirole works by replacing dopamine, a natural substance in the brain that is needed to control movement. For Parkinson's disease, typical starting doses are 0.25 mg three times daily, gradually increasing as needed. For RLS, treatment usually begins with 0.25 mg once daily, taken 1-3 hours before bedtime, with gradual adjustments based on response.
Key Points to Consider
- Common side effects include nausea, dizziness, drowsiness, and sometimes sudden sleep episodes.
- Patients should be aware that ropinirole may cause impulse control disorders in some individuals, including compulsive gambling, shopping, or sexual behavior.
- It's essential to take this medication exactly as prescribed and not to stop suddenly without consulting a healthcare provider, as abrupt discontinuation can worsen symptoms.
- The efficacy and safety of ropinirole have been demonstrated in several studies, including a recent comparison with pramipexole in the treatment of Parkinson's disease 2.
Important Considerations for Treatment
- Ropinirole has been shown to be effective in both monotherapy and combination therapy for Parkinson's disease.
- The medication has also been used successfully in the treatment of restless legs syndrome.
- When considering treatment options, it's crucial to weigh the benefits and risks of ropinirole, including its potential for impulse control disorders and other side effects.